Sunday, 14 December 2025
  
Login

Australia's most trusted
source of pharma news

Sunday, 14 December 2025
News

BioNTech opening in Australia

Posted 7 October 2022 PM

German powerhouse BioNTech has signed an in-principle partnership with the Victorian State Government to establish an Asia Pacific mRNA clinical research and development centre in Melbourne.

The facility will form part of BioNTech's global network and according to the government will see the company deliver next-generation mRNA therapeutics and vaccines for research and clinical trials - including infectious diseases, cancer medicines and personalised cancer treatments.

The biotech has become a household name after its collaboration with Pfizer to develop the mega blockbuster mRNA Covid vaccine Comirnaty.

To see the whole article, please login


Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (3)

Sales & Customer Relations (11)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (1)

Devices (1)

Other (11)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.